Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on June 29, 2026

Jun. 29, 2026

Evolution Moving Mark 12 Years in San Antonio, Family Owned Founded by 2 TX State Brothers Crosses 3,000 Customer Survey

Indeterminate EIN Presswire

Jun. 29, 2026

Evolution Moving Company Fort Worth Ranks in the Top 1.3% of Texas Movers in GreatGuysMove 2026 Industry Analysis

Indeterminate EIN Presswire

Jun. 29, 2026

EPC Group Launches Microsoft 365 Copilot Rescue Engagement for Stalled Enterprise Rollouts

Indeterminate EIN Presswire

Jun. 29, 2026

InvisRisk Expands Build Application Firewall with Real-Time CI/CD Enforcement Across AWS and GitLab

Indeterminate EIN Presswire

Jun. 29, 2026

Memory Market Uncertainty: MEMPHIS Electronic Provides Strategic Guidance at FMS 2026

Indeterminate EIN Presswire

Jun. 29, 2026

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

Indeterminate GlobeNewswire

Jun. 29, 2026

Textellent Announces Industry’s First 'Always-On' Compliance Monitoring & Solves 10DLC Bottlenecks for Franchise Brands

Indeterminate EIN Presswire

Jun. 29, 2026

NATM Vendor Conference Returns to Frisco July 20–23, 2026

Indeterminate EIN Presswire

Jun. 29, 2026

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Indeterminate GlobeNewswire

Jun. 29, 2026

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Indeterminate GlobeNewswire

Jun. 29, 2026

Beach Day API Launches Real-Time Beach and Ocean Data API for Developers

Indeterminate GlobeNewswire

Jun. 29, 2026

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

Jun. 29, 2026

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Indeterminate GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

Indeterminate GlobeNewswire

Jun. 29, 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Indeterminate GlobeNewswire

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire

Jun. 29, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Indeterminate GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

Indeterminate GlobeNewswire

Jun. 29, 2026

QuickBuzz Announces Strong Momentum Following Successful Presentation at the Global Family Investment Summit

Indeterminate GlobeNewswire